Representative before the EPO

Employment test 501 - 1000 employees
Company dna olswang llp
operating since 1981
1133.65
Headquarter in London and 8 offices
active in Legal Services and IP Consulting

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

We have observed 24 EP applications Monika Rai has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13724695

NOVEL HA BINDING AGENTS

IPC classification:
A61K 39/42, A61P 31/16, C07K 16/10
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13799829

NUCLEIC ACID AMPLIFICATIONS

IPC classification:
C07H 21/04, C12P 19/34, C12Q 1/68
Agent:
Monika Rai, Mathys & Squire LLP
Agent:
Patent Boutique LLP
Status:
GRANT OF PATENT INTENDED
EP13730258

METHOD FOR PRODUCING PLANT SEED CONTAINING ENDOPHYTIC MICRO-ORGANISMS

IPC classification:
A01C 1/06, A01N 25/00, A01N 63/04, C05F 11/08, C12N 1/04, C12R 1/01
Applicant:
AIT Austrian Institute of Technology GmbH
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13756745

METHODS AND DEVICES FOR IMMUNODIAGNOSTIC APPLICATIONS

IPC classification:
G01N 33/68, G01N 33/80
Agent:
Monika Rai, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13771732

PEPTIDE-LINKED MORPHOLINO ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF MYOTONIC DYSTROPHY

IPC classification:
C12N 15/113
Applicant:
Genzyme Corporation
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15154393

Use of TGF beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia

IPC classification:
A61K 39/00, A61K 39/395, A61K 45/06, A61P 11/00, C07K 16/22
Applicant:
Massachusetts General Hospital
Applicant:
Genzyme Corporation
Agent:
Monika Rai, Mathys & Squire LLP
Status:
The patent has been granted
EP15157254

METHODS FOR GENERATING HIGH TITER HELPER-FREE PREPARATIONS OF RELEASED RECOMBINANT AAV VECTORS

IPC classification:
C12N 7/02, C12N 15/86
Applicant:
Genzyme Corporation
Agent:
Monika Rai, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14722439

FUSION PROTEINS COMPRISING PDGF AND VEGF BINDING PORTIONS AND METHODS OF USING THEREOF

IPC classification:
A61K 38/18, C07K 14/71, C12N 5/00, C12N 15/62, C12N 15/86
Applicant:
Genzyme Corporation
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14729998

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MACULAR DEGENERATION

IPC classification:
A61K 38/17, A61P 27/02
Applicant:
Genzyme Corporation
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15191351

ANTI-HUMAN CD52 IMMUNOGLOBULINS

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/28, C12P 21/08
Applicant:
Genzyme Corporation
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14789931

POLYNUCLEOTIDES ENCODING LOW DENSITY LIPOPROTEIN RECEPTOR

IPC classification:
C07K 14/705
Applicant:
Moderna Therapeutics, Inc.
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15706595

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MACULAR DEGENERATION

IPC classification:
A61K 48/00, C07K 14/71
Applicant:
Genzyme Corporation
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15705123

ANTIBODY MOLEULES TO DENGUE VIRUS AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/42, C07K 16/10
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15708991

METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST

IPC classification:
A61K 31/00, A61K 31/167, A61K 31/56, A61K 39/395, A61P 11/06
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15712241

METHODS FOR REDUCING CARDIOVASCULAR RISK

IPC classification:
A61K 39/395, A61P 9/00, C07K 16/40
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Monika Rai, Mathys & Squire LLP
Agent:
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
EXAMINATION REQUESTED
EP15727217

METHODS OF PREPARING MATERIALS WITH AMMONIA OXIDIZING BACTERIA AND TESTING MATERIALS FOR AMMONIA OXIDIZING BACTERIA

IPC classification:
G01N 33/569
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15729283

SYSTEMS AND METHODS FOR STORAGE AND DELIVERY OF AMMONIA OXIDIZING BACTERIA

IPC classification:
A61K 35/741
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15727795

MULTIPLE OLIGONUCLEOTIDE MOIETIES ON PEPTIDE CARRIER

IPC classification:
A61K 31/712, C07K 19/00, C12N 15/113, A61K 47/50
Agent:
Monika Rai, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15774796

ULTRA-HIGH DENSITY CELL BANKING METHODS

IPC classification:
A01N 1/02, C12M 1/00, C12M 3/06
Agent:
Monika Rai, Mathys & Squire LLP
Status:
Request for examination was made
EP15772133

ADENO-ASSOCIATED VIRAL VECTORS FOR TREATING MYOCILIN (MYOC) GLAUCOMA

IPC classification:
A61K 48/00, C07K 14/435, C12N 15/864
Agent:
Monika Rai, Mathys & Squire LLP
Status:
Request for examination was made
EP15804646

METHODS FOR TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Monika Rai, Mathys & Squire LLP
Status:
Request for examination was made
EP17168189

GENE THERAPY FOR LYSOSOMAL STORAGE DISEASES

IPC classification:
A61K 38/47, A61K 48/00, C12N 15/86
Applicant:
Genzyme Corporation
Agent:
Monika Rai, Mathys & Squire LLP
Status:
The application has been published
EP17181294

USE OF TGF BETA ANTAGONISTS TO TREAT INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA

IPC classification:
A61K 39/00, A61K 39/395, A61K 45/06, A61P 11/00, C07K 16/22
Applicant:
Massachusetts General Hospital
Applicant:
Genzyme Corporation
Agent:
Monika Rai, Mathys & Squire LLP
Status:
The application has been published
EP16777342

IMMUNE CELL TRAPPING DEVICES AND METHODS FOR MAKING AND USING THE SAME

IPC classification:
A61K 35/12, A61K 35/13, A61K 35/14, A61K 35/15, A61K 35/17, A61L 27/36, A61L 27/54, A61L 27/56, C08J 9/26
Applicant:
Harvard College
Agent:
Monika Rai, Mathys & Squire LLP
Status:
Request for examination was made

Please Sign in to use this feature